Improving Precision Oncology for Lung and Prostate Cancers
This study is testing a "Multilevel Intervention" to improve how often patients with advanced lung or prostate cancer at VA medical centers receive precision oncology (PO). PO uses molecular testing to find specific changes in a tumor that can be treated with targeted therapy. The intervention has three parts: a short educational video for patients, feedback to doctors about their PO practices, and changes to the electronic medical record to make ordering and reviewing PO tests easier. The study aims to see if these changes increase the use of molecular testing over three years. You may be able to join if you are a veteran with advanced lung or prostate cancer being seen at a VA oncology clinic. The study is currently unclear on its recruitment status.
- Study design
- This interventional study plans to include 2653 participants. It is testing a multilevel intervention with three components.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary goal of the study will be measured at 3 years, which suggests a follow-up period of at least that long.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Multilevel Intervention for Precision Oncology
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Daniel J Becker, MD · PRINCIPAL_INVESTIGATOR · VA NY Harbor Healthcare System, New York, NY
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Use of molecular testing3 years
Proportion of eligible patients with lung and prostate cancer who have next generation sequencing molecular testing